Neurological adverse events related to immune checkpoint inhibitor therapy in skin cancer patients - a monocentric retrospective analysis

Documenti analoghi

• Paraneoplastic neurological syndrome: focus on the involvement of the peripheral nervous system
  di: Sitkali I.V., et al.
  Pubblicazione: (2017-03-01)
• Paraneoplastic anti-Yo antibody mediated subacute cerebellar degeneration. Case series and literature review
  di: M. Vaišvilas, et al.
  Pubblicazione: (2020-03-01)
• Rapidly progressive cerebellar syndrome as a manifestation of paraneoplastic brain damage. A case report
  di: Vera N. Grigoryeva, et al.
  Pubblicazione: (2023-10-01)
• Evaluation of warning strategies for paraneoplastic neurological syndromes associated with PD-1/PD-L1 inhibitors
  di: Zhuangzhuang Ren, et al.
  Pubblicazione: (2025-12-01)
• Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities
  di: Simone Rossi, et al.
  Pubblicazione: (2025-11-01)